ACRIVON THERAPEUTICS INC. - COMMON STOCK
1.5100
04-April-25 15:45:00
15 minutes delayed
Stocks
-0.1300
-7.93%
Today's range
1.4000 - 1.6750
ISIN
N/A
Source
NASDAQ
-
27 Mar 2025 16:44:36 By Nasdaq GlobeNewswire
-
19 Mar 2025 07:00:00 By Nasdaq GlobeNewswire
-
05 Feb 2025 07:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
13 Nov 2024 06:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16 Oct 2024 15:00:00 By Nasdaq GlobeNewswire
-
11 Oct 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Cantor Global Healthcare Conference
10 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
13 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Jefferies Global Healthcare Conference
29 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
14 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
24 Apr 2024 15:01:00 By Nasdaq GlobeNewswire
-
10 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces $130 Million Private Placement Financing
09 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
28 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >